Publications

Division/Center

The impact of NCMS policies on inpatient Health Expenditure and its equality in Rural China

Value Health
Guo N, Wang J, Shi LW, Han S, Zhu D, Gan XD

IL-10 immunodepletion from meningococcal sepsis plasma induces extensive changes in gene expression and cytokine release in stimulated human monocytes

Innate Immun
Gopinathan U, Brusletto BS, Olstad OK, Kierulf P, Berg JP, Brandtzaeg P, Øvstebø R

Racial/Ethnic differences in health care visits made before suicide attempt across the United States.

Med Care
Ahmedani BK, Stewart C, Simon GE, Lynch F, Lu CY, Waitzfelder BE, Solberg LI, Owen-Smith AA, Beck A, Copeland LA, Hunkeler EM, Rossom RC, Williams K

Asthma Treatments and Mental Health Visits After a Food and Drug Administration Label Change for Leukotriene Inhibitors.

Clin Ther
Lu CY, Zhang F, Lakoma MD, Butler MG, Fung V, Larkin EK, Kharbanda EO, Vollmer WM, Lieu T, Soumerai SB, Chen Wu A

Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies.

J Pharm Policy Pract
Hsu JC, Ross-Degnan D, Wagner AK, Cheng CL, Yang YH, Zhang F, Lu CY

Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010.

Pharmacoepidemiol Drug Saf
Larochelle MR, Zhang F, Ross-Degnan D, Wharam JF

Net clinical benefit of oral anticoagulants: a multiple criteria decision analysis.

PLoS ONE
Hsu JC, Hsieh CY, Yang YH, Lu CY

Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia.

Pac L, Horwitz MM, Namutebi AM, Auerbach BJ, Semeere A, Namulema T, Schwarz M, Bbosa R, Muruta A, Meya DB, Manabe YC.

Can genomic medicine improve financial sustainability of health systems?

Mol Diagn Ther
Lu CY, Cohen JP

National expenditure for false-positive mammograms and breast cancer overdiagnoses estimated at $4 billion a year.

Health Aff (Millwood)
Ong MS, Mandl KD

Policies and programs to facilitate access to targeted cancer therapies in Thailand.

PLoS ONE
Sruamsiri R, Ross-Degnan D, Lu CY, Chaiyakunapruk N, Wagner AK

The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.

Cancer Epidemiol. Biomarkers Prev.
Gangnon RE, Sprague BL, Stout NK, Alagoz O, Weedon-Fekjær H, Holford TR, Trentham-Dietz A

Farmácia Popular Program: changes in geographic accessibility of medicines during ten years of a medicine subsidy policy in Brazil.

J Pharm Policy Pract
Emmerick IC, do Nascimento JM, Pereira MA, Luiza VL, Ross-Degnan D,

Clinical safety of England's national programme for IT: a retrospective analysis of all reported safety events 2005 to 2011.

Int J Med Inform
Magrabi F, Baker M, Sinha I, Ong MS, Harrison S, Kidd MR, Runciman WB, Coiera E

Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts.

Radiology
Lee CI, Cevik M, Alagoz O, Sprague BL, Tosteson AN, Miglioretti DL, Kerlikowske K, Stout NK, Jarvik JG, Ramsey SD, Lehman CD

Effects of eliminating drug caps on racial differences in antidepressant use among dual enrollees with diabetes and depression.

Clin Ther
Adams AS, Soumerai SB, Zhang F, Gilden D, Burns M, Huskamp HA, Trinacty C, Alegria M, LeCates RF, Griggs JJ, Ross-Degnan D, Madden JM

A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation.

J Clin Epidemiol
Fretheim A, Zhang F, Ross-Degnan D, Oxman AD, Cheyne H, Foy R, Goodacre S, Herrin J, Kerse N, McKinlay RJ, Wright A, Soumerai SB

Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand.

J Pharm Policy Pract
Lu CY, Emmerick IC, Stephens P, Ross-Degnan D, Wagner AK

Patient access schemes in Asia-pacific markets: current experience and future potential.

J Pharm Policy Pract
Lu CY, Lupton C, Rakowsky S, Babar ZU, Ross-Degnan D, Wagner AK

The evolution of Taiwan's National Health Insurance drug reimbursement scheme.

Daru
Hsu JC, Lu CY